Foster Dykema Cabot & Co’s Pfizer PFE Stock Holding History

Foster Dykema Cabot & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$312K	Buy	9,395 +2,400	+34%	+$84.9K	0.04%	70
2023 Q2	$257K	Buy	6,995 +1,731	+33%	+$67.4K	0.03%	81
2023 Q1	$215K	Buy	5,264 +394	+8%	+$17K	0.03%	81
2022 Q4	$250K	Sell	4,870 -7,504	-61%	-$360K	0.04%	66
2022 Q3	$541K	Sell	12,374 -196	-2%	-$9.52K	0.07%	52
2022 Q2	$659K	Hold	12,570	–	–	0.08%	47
2022 Q1	$651K	Sell	12,570 -6,665	-35%	-$346K	0.08%	53
2021 Q4	$1.14M	Sell	19,235 -49	-0.3%	-$2.43K	0.13%	43
2021 Q3	$829K	Sell	19,284 -124	-0.6%	-$5.49K	0.1%	52
2021 Q2	$760K	Buy	19,408 +49	+0.3%	+$1.91K	0.09%	50
2021 Q1	$701K	Sell	19,359 -6,716	-26%	-$238K	0.09%	50
2020 Q4	$960K	Buy	26,075 +5,671	+28%	+$208K	0.13%	48
2020 Q3	$710K	Sell	20,404 -428	-2%	-$15K	0.12%	54
2020 Q2	$646K	Sell	20,832 -284	-1%	-$9.65K	0.12%	50
2020 Q1	$654K	Hold	21,116	–	–	0.13%	45
2019 Q4	$785K	Hold	21,116	–	–	0.11%	46
2019 Q3	$720K	Hold	21,116	–	–	0.11%	56
2019 Q2	$868K	Hold	21,116	–	–	0.13%	50
2019 Q1	$851K	Buy	21,116 +395	+2%	+$15.8K	0.14%	46
2018 Q4	$858K	Sell	20,721 -143	-0.7%	-$5.94K	0.16%	40
2018 Q3	$872K	Sell	20,864 -25	-0.1%	-$962	0.14%	44
2018 Q2	$765K	Sell	20,889 -265	-1%	-$9.06K	0.13%	49
2018 Q1	$712K	Sell	21,154 -327	-2%	-$11.2K	0.12%	59
2017 Q4	$738K	Sell	21,481 -147	-0.7%	-$5.01K	0.12%	57
2017 Q3	$733K	Hold	21,628	–	–	0.13%	53
2017 Q2	$689K	Hold	21,628	–	–	0.12%	59
2017 Q1	$702K	Hold	21,628	–	–	0.13%	58
2016 Q4	$666K	Hold	21,628	–	–	0.13%	62
2016 Q3	$695K	Hold	21,628	–	–	0.15%	62
2016 Q2	$723K	Sell	21,628 -483	-2%	-$15.4K	0.17%	53
2016 Q1	$622K	Hold	22,111	–	–	0.15%	54
2015 Q4	$677K	Sell	22,111 -483	-2%	-$15.2K	0.17%	50
2015 Q3	$673K	Hold	22,594	–	–	0.17%	45
2015 Q2	$719K	Buy	22,594 +5,270	+30%	+$172K	0.19%	47
2015 Q1	$572K	Hold	17,324	–	–	0.14%	52
2014 Q4	$512K	Hold	17,324	–	–	0.12%	56
2014 Q3	$486K	Sell	17,324 -6,324	-27%	-$177K	0.12%	56
2014 Q2	$666K	Hold	23,648	–	–	0.16%	48
2014 Q1	$721K	Hold	23,648	–	–	0.18%	45
2013 Q4	$687K	Hold	23,648	–	–	0.18%	47
2013 Q3	$644K	Hold	23,648	–	–	0.19%	48
2013 Q2	$628K	Buy	+23,648	New	+$653K	0.19%	46

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Foster Dykema Cabot & Co's PFE Position: Q3 2023 in Review

Foster Dykema Cabot & Co increased its Pfizer (PFE) stake by 34% in Q3 2023, buying an estimated $84.9K and bringing the position to 9,395 shares worth $312K. The position accounts for 0.04% of the portfolio, ranked #70.

Foster Dykema Cabot & Co first reported a position in PFE in Q2 2013 and has held it in 42 quarters since. The position peaked at $1.14M in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Foster Dykema Cabot & Co held 9,395 shares of Pfizer worth $312K as of Q3 2023.
Foster Dykema Cabot & Co bought 2,400 Pfizer shares in Q3 2023, an estimated $84.9K.
Pfizer made up 0.04% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #70 holding.
Foster Dykema Cabot & Co first reported a position in Pfizer in Q2 2013 and has held it in 42 quarters since.
Foster Dykema Cabot & Co's Pfizer position peaked at $1.14M in Q4 2021.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.